Diabetes study using glucose monitors for underserved patients
Part of Hormones & metabolism clinical trials.
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels all day) along with remote check-ins can help people with type 2 diabetes manage their blood sugar better. It's designed for adults with high A1c levels who may not have easy access to regular care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have type 2 diabetes
- Your A1c (average blood sugar over 3 months) is above 8%
- You have not used a real-time continuous glucose monitor for more than 6 weeks in the past 3 months
- You are not currently pregnant
- You are not on steroids, active cancer treatment, or dialysis for kidney failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels without fingersticks) helps young adults manage type 2 diabetes better. You will wear the sensor and use a phone app to track your glucose.
This trial looks at the experiences of people with type 2 diabetes who have used a continuous glucose monitor (CGM) for at least a year and are on intensive insulin therapy. The goal is to learn how CGM helps manage their condition.
This study tests whether using a continuous glucose monitor (CGM) can help people with type 2 diabetes who need insulin after leaving the hospital. It aims to improve blood sugar control during this transition period.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This trial tests a program to help low-income adults with type 1 diabetes use continuous glucose monitors (CGM). You and a family member or friend will attend four weekly sessions to learn how to get the most out of the device.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.